Pfizer

Pharmaceutical manufacturing in Ireland continues to perform very well contributing strongly to exports and economic growth and provides excellent career opportunities.

Dr Paul Duffy

Vice-President, Pfizer Global Supply

Pfizer

Pfizer is among the largest global biopharmaceutical and biotechnology companies. It operates in more than 125 countries worldwide and produces some of the best-known products and vaccines in the areas of arthritis, inflammation, cancer, anti-infectives, haemophilia, pain and stroke.

A leading employer in Ireland

Pfizer is also one of the leading employers in Ireland and was among the first pharma companies to set up in Ireland, having established in 1969 at Ringaskiddy, County Cork. Today, it employs 5,000 people across five sites in counties Cork, Dublin and Kildare.

In addition to manufacturing leading medicines and vaccines, other business activities in Ireland include shared finance and business services, scientific R&D, and commercial operations. The Grange Castle site is part of the company’s supply chain for its COVID-19 vaccine.

Continued investment into Ireland

Total capital investment by the company in Ireland exceeds $9 billion, and it continues to invest in its Irish operations. Part of Pfizer’s Worldwide Research and Development is based in Ireland. The Global Biotherapeutics Technology group at Grange Castle was established in 2006 and is part of a world-leading protein drug discovery unit within Pfizer Worldwide R&D. In 2022, Pfizer announced plans to invest over €1.2 billion at Grange Castle, with a new facility that will double capacity for biological drug substance manufacturing at the site, creating hundreds of new jobs.